Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women by Monica C Klempel et al.
Klempel et al. Nutrition Journal 2012, 11:98
http://www.nutritionj.com/content/11/1/98RESEARCH Open AccessIntermittent fasting combined with calorie
restriction is effective for weight loss and
cardio-protection in obese women
Monica C Klempel, Cynthia M Kroeger, Surabhi Bhutani, John F Trepanowski and Krista A Varady*Abstract
Background: Intermittent fasting (IF; severe restriction 1 d/week) facilitates weight loss and improves coronary
heart disease (CHD) risk indicators. The degree to which weight loss can be enhanced if IF is combined with calorie
restriction (CR) and liquid meals, remains unknown.
Objective: This study examined the effects of IF plus CR (with or without a liquid diet) on body weight, body
composition, and CHD risk.
Methods: Obese women (n = 54) were randomized to either the IFCR-liquid (IFCR-L) or IFCR-food based (IFCR-F)
diet. The trial had two phases: 1) 2-week weight maintenance period, and 2) 8-week weight loss period.
Results: Body weight decreased more (P = 0.04) in the IFCR-L group (3.9 ± 1.4 kg) versus the IFCR-F group (2.5 ±
0.6 kg). Fat mass decreased similarly (P < 0.0001) in the IFCR-L and IFCR-F groups (2.8 ± 1.2 kg and 1.9 ± 0.7 kg,
respectively). Visceral fat was reduced (P < 0.001) by IFCR-L (0.7 ± 0.5 kg) and IFCR-F (0.3 ± 0.5 kg) diets. Reductions
in total and LDL cholesterol levels were greater (P = 0.04) in the IFCR-L (19 ± 10%; 20 ± 9%, respectively) versus the
IFCR-F group (8 ± 3%; 7 ± 4%, respectively). LDL peak particle size increased (P < 0.01), while heart rate, glucose,
insulin, and homocysteine decreased (P < 0.05), in the IFCR-L group only.
Conclusion: These findings suggest that IF combined with CR and liquid meals is an effective strategy to help
obese women lose weight and lower CHD risk.
Keywords: Intermittent fasting, Calorie restriction, Liquid diet, Body weight, Visceral fat, Cholesterol, Coronary heart
disease, Obese womenIntroduction
Coronary heart disease (CHD) remains the number one
of killer of women in the United States [1]. Weight gain
during adulthood increases the risk of CHD [1]. Epi-
demiological evidence suggests that a modest reduction
in weight (i.e. 5% of body weight) in female subjects
reduces the incidence and progression of CHD [2]. Al-
though several diet strategies exist to help individuals
lose weight, one regimen that has gained considerable
popularity in the past decade is intermittent fasting (IF)
[3]. This diet strategy generally involves severe restric-
tion (75-90% of energy needs) on 1 or 2 days per week.
Results from a recent 24-week randomized clinical trial* Correspondence: varady@uic.edu
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reproduction in any medium, provided the orrevealed that IF can reduce body weight by 7% in obese
women [4]. LDL cholesterol and triglyceride concentra-
tions also decreased by 10% and 17%, respectively, in
these subjects [4]. Though these findings are promising,
this regimen is limited in that a long duration of time
(i.e. 24 weeks) is required to experience only modest
reductions in body weight. One possible method of
augmenting the rate of weight loss is to combine IF
with a daily calorie restriction (CR) protocol. In this
way, the individual would fast one day per week, and
then undergo mild CR (i.e. 20% restriction of energy
needs) on 6 days per week. This combination therapy
(IF plus CR) produces greater reductions in weight
and superior changes in CHD risk parameters when
compared to each intervention alone in animal models
[5]. Whether the beneficial effects of IF plus CR onl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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subjects has yet to be elucidated.
It is well known that many obese subjects are unable
to adequately estimate portion sizes [6]. This inability to
estimate portions during periods of dieting results in ex-
cessive food intake, which then blunts overall weight loss
[6]. In order to take the guesswork out of estimating
portion sizes, some CR protocols implement portion
controlled liquid meals to replace 1 or 2 meals per day.
When liquid meal replacements are employed, subjects
tend to lose greater amounts of weight when compared
to subjects receiving diet counseling alone [7,8].
Whether or not the implementation of liquid meal repla-
cements during periods of IF plus CR accelerates weight
loss remains unknown.
Accordingly, the objective of the present study was to
examine the effects of an IF protocol combined with CR
on body weight, body composition, and CHD risk factors
in obese women. Whether the addition of liquid meal
replacements to this protocol would result in greater
weight loss and more pronounced CHD risk reduction
was also assessed.Methods
Subjects
Subjects were recruited by means of advertisements
placed on and around the University of Illinois campusFigure 1 Study flow chart. IFCR-L: Intermittent fasting calorie restriction-liqin downtown Chicago. A total of 77 individuals
responded to the advertisements, but only 60 were
deemed eligible to participate after the preliminary ques-
tionnaire, body mass index (BMI) and waist circumfer-
ence assessment (Figure 1). Key inclusion criteria were
as follows: female, age 35–65 y, BMI between 30 and
39.9 kg/m2, waist circumference >88 cm, weight stable
for 3 months prior to the beginning of the study (i.e.
<5 kg weight loss or gain), non-diabetic, no history of
cardiovascular disease, no history of cancer, sedentary or
lightly active for 3 months prior to the beginning of the
study (i.e. <3 h/week of light-intensity exercise at 2.5–
4.0 metabolic equivalents (METS)), non-smoker, not
claustrophobic, and not taking weight loss, lipid-lower-
ing, or glucose-lowering medications. Peri-menopausal
women were excluded from the study, and post-
menopausal women (defined as absence of menses for
2 y) were required to maintain their current hormone
replacement therapy regimen for the duration of the
study. The experimental protocol was approved by the
Office for the Protection of Research Subjects at the Uni-
versity of Illinois, Chicago, and all volunteers gave
written informed consent to participate in the trial.Experimental design
Randomization was performed by way of a stratified ran-
dom sample. The sample frame was divided into stratauid diet; IFCR-F: Intermittent fasting calorie restriction-food based diet.
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then randomly assigned to either the IFCR-liquid diet
(IFCR-L) group (n = 30) or IFCR-food based diet (IFCR-F)
group (n = 30). The 10-week trial consisted of two dietary
phases: 1) a 2-week baseline weight maintenance period,
and 2) an 8-week weight loss period.Diet protocol
Baseline weight maintenance diet (Week 1–2)
Before commencing the 8-week weight loss intervention,
each subject participated in a 2-week baseline weight
maintenance period. During this period, subjects were
requested to maintain a stable weight and continue eat-
ing their usual diet.Weight loss diets (Week 3–10)
Following the baseline period, subjects participated in
the IFCR-L or IFCR-F protocol for 8 weeks. Energy
requirements were measured using the Mifflin equation
[9]. IFCR-L subjects (n = 30) consumed a calorie-
restricted liquid diet for the first 6 days of the week, and
then underwent a fast on the last day of the week (water
consumption + 120 kcal of juice powder only, for 24 h).
The liquid diet (during the CR period) consisted of a li-
quid meal replacement for breakfast (240 kcal) and a li-
quid meal replacement for lunch (240 kcal). All liquid
meal replacements were provided to the subjects in
powder-form in premeasured packets (Isalean Shake,
Isagenix LLC, Chandler, AZ). At dinnertime, IFCR-L
subjects consumed a 400–600 kcal meal. Food was not
provided to the subjects for the dinnertime meal. In-
stead, subjects met with a Registered Dietician weekly to
learn how to make healthy eating choices that are in
compliance with the National Cholesterol Education
Program Therapeutic Lifestyle Changes (TLC) diet (i.e.
<35% of kcal as fat; 50-60% of kcal as carbohydrates;
<200 mg/d of dietary cholesterol; and 20–30 g/d of
fiber). In following this regimen, each subject was calorie
restricted by 30% of their baseline needs. IFCR-F sub-
jects (n = 30) consumed a calorie-restricted food-based
diet for the first 6 days of the week, and then underwent
a fast on the last day of the week (water consumption +
120 kcal of juice powder only, for 24 h). IFCR-F subjects
ate 3 meals per day in accordance with the TLC diet
guidelines. Food was not provided to the subjects. In-
stead, subjects met with a Registered Dietician weekly to
learn how to make healthy eating choices that were in
compliance with the TLC diet. Subjects were instructed
to eat approximately 240 kcal for breakfast, 240 kcal for
lunch, and 400–600 kcal for dinner. In following this
regimen, each IFCR-F subject was calorie restricted by
30% of their baseline needs.Analyses
Adherence with diets
A 7-d food record was used to assess adherence to the
diets. Subjects completed the food records at week 3
and 10. The Registered Dietician provided 15 min of in-
struction to each participant on how to complete the
food records. These instructions included verbal infor-
mation and detailed reference guides on how to estimate
portion sizes and record food items in sufficient detail to
obtain an accurate estimate of dietary intake. All dietary
information from the food records was entered into the
food analysis program, Nutritionist Pro (Axxya Systems,
Stafford, TX) by a single trained operator to alleviate
inter-investigator bias. In addition, IFCR-L subjects were
provided with a checklist each day to monitor: 1) adher-
ence to the liquid meal protocol, and 2) adherence to
the fast day regimen. IFCR-F subjects were also given a
checklist to monitor their adherence to the fast day regi-
men. If an IFCR-L or IFCR-F subject consumed more
that 100 kcal on the fast day (above the 120 kcal of juice
powder allotted to the subject), the subject was consid-
ered non-adherent with the fast day protocol.
Maintenance of physical activity habits
Changes in daily energy expenditure associated with
alterations in physical activity habits were quantified by
the use of a pattern recognition monitor (Sense Wear
Mini (SWM), Bodymedia, Pittsburgh, PA). Subjects wore
the lightweight monitor on their upper arm for 7 d at
week 3 and 10 of the trial. The SWM is a wireless multi-
sensor activity monitor that integrates motion data from
a triaxial accelerometer along with several other physio-
logical sensors (heat flux, skin temperature and galvanic
skin response). The data was analyzed using Bodymedia
Software V.7.0, algorithm V.2.2.4 (Bodymedia, Pitts-
burgh, PA).
Body weight and body composition assessment
Body weight measurements were taken to the nearest
0.5 kg at the beginning of each week in light clothing
and without shoes using a balance beam scale (Health-
OMeter; Sunbeam Products, Boca Raton, FL). Height
was assessed using a wall-mounted stadiometer to the
nearest 0.1 cm. BMI was assessed as kg/m2. Fat mass
and fat free mass were assessed by dual energy X-ray ab-
sorptiometry (DXA) at weeks 1, 3 and 10 (QDR 4500 W,
Hologic Inc. Arlington, MA). Waist circumference was
measured by a flexible tape to the nearest 0.1 cm, mid-
way between the lower costal margin and super iliac
crest during a period of expiration. Abdominal visceral
adipose tissue and subcutaneous adipose tissue volumes
were quantified using magnetic resonance imaging
(MRI) at week 3 and 10 [10]. Images were acquired
using a 1.5-T superconducting magnet (Siemens, Iselin,
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vertebra (T9) to the first sacral vertebra (S1). Image
locations were defined relative to a common anatomical
landmark, the L4–L5 intervertebral space. To facilitate
the comparison of individual image data, we limited our
analyses to the set of images ranging from 20 cm above
L4–L5 (+20 cm) to 3 cm below L4–L5 (−3 cm), for a
total of 24 images per subject. Segmentation of the axial
images into visceral adipose tissue and subcutaneous
adipose tissue areas (cm2) was performed using Hippo-
Fat image analysis software [11]. Visceral adipose tissue
and subcutaneous adipose tissue areas were summed
across all 24 images to obtain visceral adipose tissue and
subcutaneous adipose tissue volumes, and then these
volumes were multiplied by 0.916 g/cm3, the density of
adipose tissue, to obtain total visceral adipose tissue
mass (kg) and total subcutaneous adipose tissue mass
(kg) [10].
Blood collection protocol
Twelve-hour fasting blood samples were collected be-
tween 6.00 am and 9.00 am at weeks 1, 3 and 10. The
subjects were instructed to avoid exercise, alcohol, and
coffee for 24 h before each visit. Blood was centrifuged
for 10 min at 520 × g at 4°C to separate plasma from
red blood cells and was stored at −80°C until analyzed.
Plasma lipid and LDL particle size determination
Plasma total cholesterol, direct LDL cholesterol, HDL
cholesterol, and triglyceride concentrations were mea-
sured in duplicate by enzymatic kits (Biovision Inc,
Mountainview, CA). The interassay coefficient of varia-
tions (CV) for total cholesterol, LDL cholesterol, HDL
cholesterol, and triglycerides were 2.4%, 3.7%, 4.0%, and
3.5%, respectively. LDL particle size was measured by
linear polyacrylamide gel electrophoresis (Quantimetrix
Lipoprint System, Redondo Beach, CA) [12]. High-
resolution 3% polyacrylamide gel tubes were used for
electrophoresis. Briefly, 25 μL of sample was mixed with
200 μL of liquid loading gel containing Sudan black, and
added to the gel tubes. After photopolymerization at
room temperature for 30 min, samples were electro-
phoresed for 1 h (3 mA/gel tube). Lipoware computer
software (Quantimetrix, Redondo Beach, CA) was then
used to divide LDL into small (<255 Å), medium (255–
260 Å), and large (>260 Å) particles [12].
Coronary heart disease risk indicator assessment
Blood pressure and heart rate were measured in tripli-
cate each week using a digital automatic blood pressure/
heart rate monitor (Omron HEM 705 LP, Kyoto, Japan)
with the subject in a seated position after a 10-min rest.
Fasting plasma glucose was measured in duplicate at
week 1, 3, and 10 with a glucose hexokinase reagent kit(A-gent glucose test, Abbott, South Pasadena, CA; inter-
assay CV: 2.8%). Insulin, C-reactive protein (CRP),
homocysteine, adiponectin, and leptin were assessed in
duplicate at week 1, 3, and 10 by ELISA (R&D Systems,
Minneapolis, MN; inter-assay CVs: 3.0%, 3.4%, 3.9%,
4.7%, and 4.2%, respectively).
Statistics
Results are presented as mean ± SEM. An independent
samples t-test was used to test baseline differences be-
tween groups. Repeated-measures ANOVA was per-
formed (taking time as the within-subject factor and diet
as the between-subject factor) to assess differences
between groups over the course of the study. Post-hoc
analyses were performed using the Tukey test. Differ-
ences were considered significant at P < 0.05. All data
was analyzed using SPSS software (version 20.0, SPSS
Inc, Chicago, IL).
Results
Subject dropout and baseline characteristics
Of the 30 subjects that were randomized to the IFCR-L
group, 1 subject dropped out due to scheduling conflicts
and 1 subject dropped out because they could not ad-
here to the diet (Figure 1). Thus 28 subjects completed
the IFCR-L protocol. Of the 30 subjects that were rando-
mized to the IFCR-F group, 2 dropped out due to sched-
uling conflicts and 2 others dropped out because they
could not adhere to the diet. Baseline characteristics of
the IFCR-L and IFCR-F groups are reported in Table 1.
There were no differences between groups for age, eth-
nicity, menopausal status, waist circumference, BMI,
plasma lipids, fasting glucose, or insulin.
Adherence to diets and physical activity maintenance
During the weight loss period (weeks 3–10), adherence
to the liquid meal protocol was 92 ± 3% in the IFCR-L
group over the course of the 8 weeks. IFCR-F subjects
achieved their energy restriction goal on 80 ± 2% of
the CR days during each week. As for fast day compliance,
there were no differences between groups (P = 0.91) (96 ±
4% and 98 ± 3% compliance for the IFCR-F and IFCR-L
groups, respectively). The degree of CR achieved during
the weight loss period by the IFCR-L group (29 ± 3%)
was greater (P < 0.05) than that achieved by the IFCR-F
(22 ± 4%). The macronutrient composition of the IFCR-L
diet (28 ± 2% kcal from fat, 20 ± 1% kcal from protein,
52 ± 3% kcal from carbs) did not differ from that of the
IFCR-F diet (31 ± 2% kcal from fat, 19 ± 2% kcal from
protein, 50% ± 3 kcal from carbs) during the 8-week
intervention. Alterations in physical activity habits were
quantified by the use of a pattern recognition monitor
(i.e. an accelerometer). There were no differences in activity
energy expenditure between baseline and post-treatment in
Table 1 Subject characteristics at baseline 1
Characteristic IFCR-L IFCR-F
n 28 26
Age (y) 47 ± 2 48 ± 2
Ethnicity




Pre-menopausal women 16 14
Post-menopausal women 12 12
Body weight (kg) 95 ± 3 94 ± 3
Height (cm) 165 ± 2 164 ± 2
Waist circumference (cm) 103 ± 1 102 ± 3
Body mass index (kg/m2) 35 ± 1 35 ± 1
Total cholesterol (mg/dl) 185 ± 8 188 ± 7
LDL cholesterol (mg/dl) 110 ± 7 115 ± 6
HDL cholesterol (mg/dl) 57 ± 4 55 ± 3
Triglycerides (mg/dl) 71 ± 7 81 ± 8
Glucose (mg/dl) 120 ± 2 120 ± 3
Insulin (uIU/ml) 14 ± 1 15 ± 2
1 Values reported as mean ± SEM. IFCR-L: Intermittent fasting calorie
restriction-liquid diet; IFCR-F: Intermittent fasting calorie restriction-food based
diet. No differences between groups for any parameter (Independent samples
t-test).
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27 kcal/d, P = 0.24), and the IFCR-F group (week 3: 246 ±
37 kcal/d, week 10: 258 ± 43 kcal/d, P = 0.63).
Weight loss and body composition
Changes in body weight and body composition are
reported in Figure 2. During the weight maintenance
period, body weight remained stable in both the IFCR-L
group (week 1: 95 ± 3, week 3: 95 ± 3 kg) and IFCR-FFigure 2 Body weight and body composition changes during the wei
diet (n = 28); IFCR-F: Intermittent fasting calorie restriction-food based diet
Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue. A. Ch
IFCR-F groups. IFCR-L group lost more body weight (P = 0.04) compared to
values significantly different from baseline (week 3) absolute values, P < 0.0
and abdominal subcutaneous adipose tissue in the IFCR-L and IFCR-F grou
3) absolute values, P < 0.001 (Repeated-measures ANOVA).group (week 1: 94 ± 3, week 3: 94 ± 3 kg). During the
weight loss period, body weight decreased (P < 0.0001)
by 3.9 ± 1.4 kg (4.1 ± 1.5%) in the IFCR-L group and by
2.5 ± 0.6 kg (2.6 ± 0.4%) in the IFCR-F group. Thus, at
week 10, body weight of the IFCR-L and IFCR-F group
was 91 ± 3 kg and 91 ± 2 kg, respectively. The IFCR-L
group lost more body weight compared to the IFCR-F
group (P = 0.04). BMI decreased (P < 0.0001) by 1.3 ± 0.5
and 0.8 ± 0.5 kg/m2, respectively, in the IFCR-L and
IFCR-F groups. Fat mass decreased (P < 0.0001) in the
IFCR-L and IFCR-F groups by 2.8 ± 1.2 kg and 1.9 ± 0.7 kg,
respectively. Fat free mass remained unchanged through-
out the course of the trial in both groups. Visceral fat
was reduced (P < 0.001) in the IFCR-L (0.7 ± 0.5 kg) and
IFCR-F (0.3 ± 0.5 kg) groups after 8 weeks of treatment.
Abdominal subcutaneous fat was not affected by either
intervention. There were no differences between groups
for fat mass, fat free mass, visceral adipose tissue, or ab-
dominal subcutaneous adipose tissue at any time point.
Figure 3 depicts the change in visceral and subcutaneous
adipose tissue in one subject in the IFCR-L group before
and after the intervention.
Plasma lipids and LDL particle size
Plasma lipids did not change during the baseline period
in either the IFCR-L or IFCR-F group. Changes in
plasma lipid concentrations during the weight loss
period are displayed in Figure 4. Total cholesterol con-
centrations decreased (P = 0.04) to a greater extent in
the IFCR-L group (19 ± 10%) compared to the IFCR-F
group (8 ± 3%). LDL cholesterol concentrations were
also reduced (P = 0.03) to a greater degree by the IFCR-L
diet (20 ± 9%) versus the IFCR-F diet (7 ± 4%). HDL
cholesterol was not affected by either intervention. Trigly-
cerides decreased (P < 0.0001) in the IFCR-L group only
(17 ± 9%). Changes in LDL particle size characteristicsght loss period. IFCR-L: Intermittent fasting calorie restriction-liquid
(n = 26); BW: Body weight; FM: Fat mass; FFM: Fat free mass, VAT:
anges in body weight, fat mass, and fat free mass in the IFCR-L and
the IFCR-F group (Repeated-measures ANOVA). *Week 10 absolute
001 (Repeated-measures ANOVA). B. Changes in visceral adipose tissue
ps. *Week 10 absolute values significantly different from baseline (week
Figure 3 Change in visceral and subcutaneous adipose tissue
area after the IFCR-L intervention. A. Abdominal visceral fat
(58 cm2) and subcutaneous fat (245 cm2) before the intermittent
fasting calorie restriction-liquid diet (IFCR-L) at the L3-L4 vertebrae
(week 3). B. Abdominal visceral fat (17 cm2) and subcutaneous fat
(173 cm2) after the IFCR-L regimen at the L3-L4 vertebrae (week 10).
Figure 4 Plasma lipid changes during the weight loss period.
IFCR-L: Intermittent fasting calorie restriction-liquid diet (n = 28);
IFCR-F: Intermittent fasting calorie restriction-food based diet
(n = 26); TC: Total cholesterol; LDL: Low density lipoprotein
cholesterol; HDL: High density lipoprotein cholesterol; TG:
Triglycerides. *Week 10 values significantly different from baseline
(week 3) values, P < 0.01 (Repeated-measures ANOVA). IFCR-L group
experienced significantly greater reductions in total cholesterol and
LDL cholesterol concentrations when compared to the IFCR-F group
(P < 0.05) (Repeated-measures ANOVA).
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(P < 0.01) by 2 ± 1 Å in the IFCR-L group only. The pro-
portion of large and medium particles was augmented
(P < 0.05) by the IFCR-L diet, but not the IFCR-F diet.
The proportion of small particles was reduced (P < 0.05)
in the both the IFCR-L (week 3: 37 ± 1%, week 10: 28 ±
2%) and IFCR-F groups (week 3: 39 ± 1%, week 10: 36 ±
1%). However, a greater reduction (P < 0.05) in the pro-
portion of small particles was noted in the IFCR-L group.
Coronary heart disease risk indicators
There were no changes in CHD risk parameters during
the weight maintenance period. Changes in CHD risk in-
dices during the weight loss period are displayed in
Table 3. Blood pressure was not altered by either the
IFCR-L or IFCR-F intervention. Heart rate decreased
(P < 0.05) in the IFCR-L group only. Glucose and insulin
concentrations decreased (P < 0.05) by the IFCR-L diet,
but were not affected by the IFCR-F diet. CRP remained
unchanged in both intervention groups. Homocysteineconcentrations decreased (P < 0.01) in the IFCR-L group
only. Adiponectin and leptin levels were reduced (P < 0.01)
by both the IFCR-L and IFCR-F diets.
Discussion
Our findings show, for the first time, that the combin-
ation of IF plus CR is an effective means of reducing
body weight, fat mass, and visceral fat mass in obese
women. This novel regimen also decreased key indica-
tors of CHD risk, such as LDL cholesterol, triglycerides,
and the proportion of small LDL particles. When liquid
meal replacements were incorporated into the IFCR
regimen, greater reductions in body weight and indica-
tors of heart disease risk were noted.
Studies of IF in human populations are very limited.
To our knowledge, only two studies have examined the
effect of IF on body weight [4,13]. In a trial conducted
by Williams et al. [13], obese subjects consumed a very-
low calorie diet (VLCD; <500 kcal/d) 1 day per week,
and ate ad libitum every other day of the week. After
20 weeks of treatment, body weight decreased by 9%
(9 kg) from baseline [13]. Similar decreases in body
weight were also observed in a recent trial by Harvie
et al. [4]. In this study, obese women underwent 2 days
of VLCD (600 kcal/d) and ate ad libitum on every other
day of the week, for 24 weeks [4]. Body weight was
reduced by 7% (6 kg), fat mass decreased by 13% (4 kg),
and waist circumference (an indirect indicator of visceral
fat) decreased by 6% (6 cm) [4]. In the present study, we
observed modest weight loss in both the IFCR-L and
IFCR-F groups after 8 weeks of treatment. We also
Table 2 LDL particle size changes during the weight loss period 1
IFCR-L IFCR-F
Week 3 Week 10 Change 2 Week 3 Week 10 Change 2
LDL peak size (Å) 260 ± 1 262 ± 1 3 2 ± 1 4 261 ± 1 261 ± 1 0 ± 1
Proportion large particles (%) 34 ± 1 39 ± 1 3 5 ± 2 35 ± 1 37 ± 1 2 ± 1
Proportion medium particles (%) 29 ± 2 33 ± 2 3 4 ± 4 26 ± 2 27 ± 2 1 ± 2
Proportion small particles (%) 37 ± 1 28 ± 2 3 −9 ± 4 4 39 ± 1 36 ± 1 3 −3 ± 1
1 Values reported as mean ± SEM. IFCR-L: Intermittent fasting calorie restriction-liquid diet (n = 28); IFCR-F: Intermittent fasting calorie restriction-food based diet
(n = 26). Small LDL particles (<255 Å), medium LDL particles (255–260 Å), and large LDL particles (>260 Å).
2 Change expressed as the difference between week 3 and week 10 absolute values.
3 Week 3 values significantly (P < 0.05) different from week 10 values within group (Repeated-measures ANOVA).
4 Absolute change significantly different (P < 0.05) between the IFCR-L and IFCR-F group (Repeated-measures ANOVA).
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col resulted in greater weight loss (IFCR-L group: 4.1%
weight loss versus IFCR-F group: 2.6% weight loss).
Reductions in fat mass and visceral fat mass were also
demonstrated at the end of the trial, but did not differ
between groups. As for fat free mass, no significant
changes were noted in either intervention group. This is
surprising as a previous study that implemented energy
restricted liquid meals observed small but significant
decreases in fat free mass (i.e. 3% reductions from base-
line) after 8 weeks of treatment [14]. The greater weight
loss by the IFCR-L intervention is most likely due to bet-
ter dietary adherence. Analysis of food intake revealed a
greater degree of energy restriction in the IFCR-L group
(29%) compared to the IFCR-F group (22%) over the
course of the trial. This greater overall restriction in the
IFCR-L group, and hence better adherence, is not sur-
prising as these subjects were given portion-controlled
liquid meals for breakfast and lunch everyday. Providing
such meals has been shown to boost initial weight loss
during dietary restriction protocols as it takes the guess-
work out of having to estimate calories from varying
foods [7]. Although these liquid meals are effective forTable 3 Coronary heart disease risk parameter changes durin
IFCR-L
Week 3 Week 10 C
Systolic BP (mm Hg) 120 ± 3 118 ± 2
Diastolic BP (mm Hg) 83 ± 3 79 ± 3
Heart rate (bpm) 73 ± 3 70 ± 4 3
Glucose (mg/dl) 120 ± 2 116 ± 2 3
Insulin (uIU/ml) 14 ± 1 11 ± 1 3
C-Reactive protein (mg/dl) 0.4 ± 0.1 0.4 ± 0.1
Homocysteine (ng/dl) 10 ± 1 8 ± 1 3
Adiponectin (ng/ml) 7893 ± 1002 5462 ± 576 3 −
Leptin (ng/ml) 37 ± 3 27 ± 3 3
1 Values reported as mean ± SEM. IFCR-L: Intermittent fasting calorie restriction-liqu
(n = 26); BP: Blood pressure.
2 Change expressed as the difference between week 3 and week 10 absolute value
3 Week 3 values significantly (P < 0.05) different from week 10 values within group
4 Absolute change significantly different (P < 0.05) between the IFCR-L and IFCR-F ghelping with initial weight loss, lasting weight loss and
weight maintenance requires extensive dietary counsel-
ing to instill healthy behaviors that can be employed
long-term [8,15]. In view of this, both groups met with a
Registered Dietician weekly to incorporate TLC dietary
guidelines into their daily lives and to help make the leap
from the liquid diet to a wholesome food-based regimen
after the study was over.
Beneficial modulations in key lipid risk factors were
also observed by both diets. For instance, total and LDL
cholesterol decreased in the IFCR-L group (19% and
20%, respectively) and IFCR-F group (8% and 7%, re-
spectively), with greater changes noted for IFCR-L. In
contrast, only the IFCR-L group experienced reductions
in triglycerides (17% from baseline). The proportion of
small LDL particles was also decreased by both the
IFCR-L group (week 3: 37 ± 1%, week 10: 28 ± 2%) and
IFCR-F group (week 3: 39 ± 1%, week 10: 36 ± 1%).
However, increases in LDL peak particle size and the
proportion of large LDL particles, were only noted in
the IFCR-L group. Taken together, these results suggest
that IF combined with CR is an effective means of im-
proving lipid profile in a short-term (8 week)g the weight loss period 1
IFCR-F
hange 2 Week 3 Week 10 Change 2
−2 ± 6 116 ± 4 114 ± 2 −2 ± 4
−4 ± 4 80 ± 3 80 ± 2 0 ± 3
−3 ± 4 4 78 ± 2 81 ± 2 3 ± 2
−4 ± 3 120 ± 3 117 ± 3 −3 ± 4
−3 ± 3 15 ± 2 13 ± 2 −2 ± 2
0 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 −0.2 ± 0.2
−2 ± 1 4 10 ± 1 10 ± 1 0 ± 1
2431 ± 802 8442 ± 1201 5931 ± 964 3 −2511 ± 771
−10 ± 2 38 ± 2 29 ± 2 3 −9 ± 2




Klempel et al. Nutrition Journal 2012, 11:98 Page 8 of 9
http://www.nutritionj.com/content/11/1/98intervention. We also show that adding a liquid diet
component may enhance this lipid-lowering effect. The
greater decreases in plasma lipids by the IFCR-L diet is
most likely due to the greater weight loss noted in this
group. For every kg of body weight loss, LDL cholesterol
is estimated to decrease by 2 mg/dl [16]. Since the
IFCR-L group lost 1.4 kg more body weight than the
IFCR-F group, this may explain why the reductions in
LDL cholesterol by the liquid diet intervention were
more pronounced. The decreases in lipids demonstrated
in the present study are similar to what has been
reported in previous trials of IF [4,13]. Williams et al.
[13] noted a 10% and 52% lowering of LDL cholesterol
and triglycerides, respectively, after 20 weeks of treat-
ment. In accordance with these findings, Harvie et al. [4]
observed a 10% decrease in LDL cholesterol and a 17%
reduction in triglycerides. No trial to date has examined
the effect of IF on LDL particle size, thus there is no
data for which to compare our findings.
Modulations in other CHD risk parameters were also
more pronounced in the IFCR-L group compared to the
IFCR-F group. For instance, fasting plasma glucose and
insulin were only decreased by the liquid intervention,
suggesting that this diet therapy may benefit glycemic
control. Heart rate and homocysteine concentrations
were reduced solely in the IFCR-L group. Leptin concen-
trations, on the other hand, were lowered by both diets.
The decreases in leptin are most likely mediated by the
reductions in fat mass and visceral fat mass observed in
both groups [17]. Leptin may be involved in atheroscler-
otic plaque formation through its effect on cholesterol
biosynthesis in monocytes [18]. Thus, these reductions
in leptin by IFCR may play a systemic anti-atherogenic
role [19]. Adiponectin levels were also decreased by both
diet interventions. This finding is not surprising, as adi-
ponectin levels have been shown to decrease during the
first 8–12 weeks of CR, and then increase only once a
10% weight loss has been achieved [20]. Since the
present trial only ran for 8 weeks, and since weight loss
was <5%, this may explain why adiponectin concentra-
tions were lowered from baseline. Blood pressure and
CRP also remained unchanged throughout the course of
the trial in both groups. Accumulating evidence suggest
that a 5 and 10% reduction in body weight is required to
decrease blood pressure and CRP, respectively [21,22].
This degree of weight loss was not attained, which may
explain why these two variables were unaffected by ei-
ther treatment.
This study is limited in that it did not tease apart the
effect of IF and CR on body weight and CHD risk. Thus,
the independent contributions of the IF diet versus the
CR diet on these various parameters, are not known. In
order to answer these key questions, a future study
should be performed that compares the effect of IFcombined with CR, to that of IF alone, and CR alone.
An additional limitation of the study was that it did not
carefully control for food intake by providing food-based
meals to the intervention groups (i.e. dinner meal for
the IFCR-L subjects, and 3 meals/d for the IFCR-F sub-
jects). If meals were provided, a more precise measure-
ment of energy restriction and dietary adherence could
have been obtained. The study is also limited in that it
employed HippoFat software to quantify visceral fat
mass from MRI images. This software is limited in that
it underestimates visceral fat and overestimates subcuta-
neous fat, particularly in larger individuals [11]. Another
limitation of the study is that we employed food records
to estimate overall calorie restriction in each group. It is
well known that obese individuals underreport food in-
take by 20-40% when completing food records [23]. Fu-
ture studies in this field should therefore implement
more robust measures of energy assessment such as the
doubly-labeled water technique [24]. The last disadvan-
tage of the study is that only female subjects were
employed, and as such, the applicability of these findings
to males remains uncertain.
In summary, these findings suggest that IFCR may be
effective for reducing body weight, visceral fat mass, and
CHD risk in obese women. We also report that incorp-
orating liquid meal replacements into an IFCR regimen
may facilitate greater weight loss and lipid-lowering.
From a clinical standpoint, we would recommend this
diet to individuals who wish to boost the weight loss
they see with IF, by adding a daily CR regimen. This
combination may also help reduce the boredom typically
associated with attempting only one dietary plan. Al-
though these short-term findings are promising, the
long-term effects of this novel diet strategy still require
confirmation in a large-scale human trial.
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